YMAB

Y-mAbs Therapeutics, Inc. - Common Stock (YMAB)

About Y-mAbs Therapeutics, Inc. - Common Stock (YMAB)

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in Princeton, NJ.

Details

Daily high

$4.92

Daily low

$4.63

Price at open

$4.90

52 Week High

$16.11

52 Week Low

$3.55

Market cap

223.3M

Dividend yield

0.00%

Volume

99,962

Avg. volume

180,724

P/E ratio

-7.78

Y-mAbs Therapeutics, Inc. - Common Stock News